These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2173608)

  • 41. Cerebrospinal fluid anti-SSA autoantibodies in primary Sjogren's syndrome with central nervous system involvement.
    Mégevand P; Chizzolini C; Chofflon M; Roux-Lombard P; Lalive PH; Picard F
    Eur Neurol; 2007; 57(3):166-71. PubMed ID: 17213724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monoclonal antibody defined T cell subsets in primary and secondary Sjögren's syndrome.
    Fossaluzza V; Rossi P; Tosato F; Pirrone S; Tonutti E; Sala PG
    Boll Ist Sieroter Milan; 1986; 65(5):440-2. PubMed ID: 3493793
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation antigens in patients with Sjögren's syndrome.
    Zeher M; Pálóczi K; Szegedi G
    Haematologia (Budap); 1990; 23(4):193-7. PubMed ID: 2101803
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunologic and structural studies of the lupus/Sjögren's syndrome autoantigen, La/SSB, with a monoclonal antibody.
    Harley JB; Rosario MO; Yamagata H; Fox OF; Koren E
    J Clin Invest; 1985 Aug; 76(2):801-6. PubMed ID: 2411763
    [TBL] [Abstract][Full Text] [Related]  

  • 45. H1N1 vaccination in Sjögren's syndrome triggers polyclonal B cell activation and promotes autoantibody production.
    Brauner S; Folkersen L; Kvarnström M; Meisgen S; Petersen S; Franzén-Malmros M; Mofors J; Brokstad KA; Klareskog L; Jonsson R; Westerberg LS; Trollmo C; Malmström V; Ambrosi A; Kuchroo VK; Nordmark G; Wahren-Herlenius M
    Ann Rheum Dis; 2017 Oct; 76(10):1755-1763. PubMed ID: 28760805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A role for lymphotoxin in primary Sjogren's disease.
    Shen L; Suresh L; Wu J; Xuan J; Li H; Zhang C; Pankewycz O; Ambrus JL
    J Immunol; 2010 Nov; 185(10):6355-63. PubMed ID: 20952683
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Failure to detect antibodies to extracellular loop peptides of the muscarinic M3 receptor in primary Sjögren's syndrome.
    Cavill D; Waterman SA; Gordon TP
    J Rheumatol; 2002 Jun; 29(6):1342-4. PubMed ID: 12064859
    [No Abstract]   [Full Text] [Related]  

  • 48. Serological diagnosis of primary Sjögren's syndrome by means of human recombinant La (SS-B) as nuclear antigen.
    Whittingham S; Naselli G; McNeilage LJ; Coppel RL; Sturgess AD
    Lancet; 1987 Jul; 2(8549):1-3. PubMed ID: 2885503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome.
    Terada K; Katamine S; Eguchi K; Moriuchi R; Kita M; Shimada H; Yamashita I; Iwata K; Tsuji Y; Nagataki S
    Lancet; 1994 Oct; 344(8930):1116-9. PubMed ID: 7934493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Precipitating autoantibodies in Sjogren's disease.
    ANDERSON JR; GRAY KG; BECK JS; KINNEAR WF
    Lancet; 1961 Aug; 2(7200):456-60. PubMed ID: 13683222
    [No Abstract]   [Full Text] [Related]  

  • 51. Increased serum CA 19-9 antibodies in Sjögren's syndrome.
    Safadi R; Ligumsky M; Goldin E; Ilan Y; Haviv YS; Nusair S
    Postgrad Med J; 1998 Sep; 74(875):543-4. PubMed ID: 10211329
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibody to a high-prevalence blood group antigen Ata associated with Sjögren's syndrome.
    Mathur S; Sawhney H; Bertoni MA; Gupta R
    Ann Hematol; 2008 Jun; 87(6):497-8. PubMed ID: 18074134
    [No Abstract]   [Full Text] [Related]  

  • 53. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome.
    Gottenberg JE; Mignot S; Nicaise-Rolland P; Cohen-Solal J; Aucouturier F; Goetz J; Labarre C; Meyer O; Sibilia J; Mariette X
    Ann Rheum Dis; 2005 Jan; 64(1):114-7. PubMed ID: 15231509
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
    Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
    Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cellular-versus-humoral autoimmune responses to salivary gland in Sjögren's syndrome.
    Anderson LG; Tarpley TM; Talal N; Cummings NA; Wolf RO; Schall GL
    Clin Exp Immunol; 1973 Mar; 13(3):335-42. PubMed ID: 4573763
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A prospective immunofluorescence study of immune deposits in the skin of primary Sjögren's syndrome.
    Velthuis PJ; Nieboer C; Kater L; Hené RJ
    Acta Derm Venereol; 1989; 69(6):487-91. PubMed ID: 2575320
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Sjogren's syndrome. Study of the immune response].
    Andrada JA; Carchak MA; Comini E
    Medicina (B Aires); 1966; 26(2):91-7. PubMed ID: 5961181
    [No Abstract]   [Full Text] [Related]  

  • 58. [Prevalence and significance of immunoglobulin G-anti-cyclic citrullinated peptide antibodies in primary Sjogren's syndrome patients].
    Liu Y; Wang YF; Wang KL; Lv FF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 46(3):478-82. PubMed ID: 24943033
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autoimmune thyroiditis and anti-thyroid antibodies in primary Sjogren's syndrome: a case-control study.
    Tunc R; Gonen MS; Acbay O; Hamuryudan V; Yazici H
    Ann Rheum Dis; 2004 May; 63(5):575-7. PubMed ID: 15082490
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Characterization of B cell lines spontaneously established from the peripheral blood of Sjögren's syndrome].
    Yamaoka K; Miyasaka N; Okuda M; Sato K; Nishioka K; Yamamoto K
    Arerugi; 1986 Jul; 35(7):481-4. PubMed ID: 3022688
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.